Breaking News
FDA Chief Says No Solid Evidence Supporting Hepatitis B Vaccine At Birth
Evergreen, Colorado: Another Killing Zone in America
Trump Cryptically Writes "Here We Go!" In Reaction To Russia-Poland Drone Incident, Oil Sp
Qatar Says It Reserves Right To Retaliate Against 'Barbaric' Netanyahu
Top Tech News
Methylene chloride (CH2Cl?) and acetone (C?H?O) create a powerful paint remover...
Engineer Builds His Own X-Ray After Hospital Charges Him $69K
Researchers create 2D nanomaterials with up to nine metals for extreme conditions
The Evolution of Electric Motors: From Bulky to Lightweight, Efficient Powerhouses
3D-Printing 'Glue Gun' Can Repair Bone Fractures During Surgery Filling-in the Gaps Around..
Kevlar-like EV battery material dissolves after use to recycle itself
Laser connects plane and satellite in breakthrough air-to-space link
Lucid Motors' World-Leading Electric Powertrain Breakdown with Emad Dlala and Eric Bach
Murder, UFOs & Antigravity Tech -- What's Really Happening at Huntsville, Alabama's Space Po
Tiny briefcase engine boosts EV range beyond battery power 
Scientists claim they've completed the first successful gene therapy against human ageing
The CEO of Bioviva USA Inc, Elizabeth Parrish, claims to be the first human in world history to have successfully reversed the effects of natural ageing - thanks to experimental gene therapy provided by her company.
Parrish first underwent gene therapy in 2015 - one designed to protect against muscle mass depletion that is inherent to ageing and another to fight stem cell depletion due to age-related diseases.
Originally meant to prove that her company's gene therapy was safe, the results - should they prove to be effective in the long-term and withstand due scientific scrutiny - would be the very first successful demonstration of telomere lengthening in any human.
"Current therapeutics offer only marginal benefits for people suffering from diseases of ageing. Additionally, lifestyle modification has limited impact for treating these diseases. Advances in biotechnology is the best solution, and if these results are anywhere near accurate, we've made history," Parrish notes.